Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma.

× No keyword cloud information.

18 in total

Review 1. Classification and management of refractory coeliac disease.

Authors: Alberto Rubio-Tapia; Joseph A Murray
Journal: Gut Date: 2010-04 Impact factor: 23.059

2. CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review.

Authors: Sheetal M Kircher; Sandeep Gurbuxani; Sonali M Smith
Journal: J Gastrointest Cancer Date: 2007

3. CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review.

Authors: Sheetal M Kircher; Sandeep Gurbuxani; Sonali M Smith
Journal: J Gastrointest Cancer Date: 2007

Review 4. Celiac disease: risk assessment, diagnosis, and monitoring.

Authors: Mala Setty; Leonardo Hormaza; Stefano Guandalini
Journal: Mol Diagn Ther Date: 2008 Impact factor: 4.074

Review 5. How to manage adult coeliac disease: perspective from the NHS England Rare Diseases Collaborative Network for Non-Responsive and Refractory Coeliac Disease.

Authors: Elisabeth Megan Rose Baggus; Marios Hadjivassiliou; Simon Cross; Hugo Penny; Heidi Urwin; Sarah Watson; Jeremy Mark Woodward; David S Sanders
Journal: Frontline Gastroenterol Date: 2019-08-08

6. Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells.

Authors: V De Re; M P Simula; L Caggiari; N Orzes; M Spina; A Da ponte; L De Appollonia; R Dolcetti; V Canzonieri; R Cannizzaro
Journal: Clin Exp Immunol Date: 2007-03-05 Impact factor: 4.330

7. Adult celiac disease and its malignant complications.

Authors: Hugh J Freeman
Journal: Gut Liver Date: 2009-12-31 Impact factor: 4.519

8. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present.

Authors: Santiago Vivas; Jose G Ruiz de Morales; Sabino Riestra; Laura Arias; Dolores Fuentes; Noemi Alvarez; Sara Calleja; Mercedes Hernando; Blanca Herrero; Javier Casqueiro; Luis Rodrigo
Journal: World J Gastroenterol Date: 2009-10-14 Impact factor: 5.742

9. The management of refractory coeliac disease.

Authors: Jeremy Woodward
Journal: Ther Adv Chronic Dis Date: 2013-03 Impact factor: 5.091

10. Refractory celiac disease and sprue-like intestinal disease.

Authors: Hugh James Freeman
Journal: World J Gastroenterol Date: 2008-02-14 Impact factor: 5.742